| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Innovation Pharmaceuticals Inc (OTCQB: IPIX)
IPIX Technical Analysis
5
| As on 9th Jun 2023 IPIX STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IPIXSTOCK Price
| Open | 0.02 | Change | Price | % |
| High | 0.02 | 1 Day | 0.00 | 0.00 |
| Low | 0.02 | 1 Week | 0.00 | 0.00 |
| Close | 0.02 | 1 Month | 0.00 | 0.00 |
| Volume | 52500 | 1 Year | -0.04 | -66.67 |
| 52 Week High 0.06 | 52 Week Low 0.01 | ||||
OTCQB USA Most Active Stocks
| BMIX | 0.01 | % |
| MOBQ | 0.18 | -5.26% |
| FNMA | 0.45 | 0.00% |
| ALPP | 3.56 | -0.80% |
| ALPP | 3.56 | -0.80% |
| SHMP | 0.06 | 0.00% |
| NWBO | 0.73 | 0.00% |
| VPLM | 0.08 | % |
| NLST | 3.72 | -8.60% |
| SRNA | 2.78 | 14.88% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| IPIX Daily Charts |
IPIX Intraday Charts |
Whats New @ Bazaartrend |
IPIX Free Analysis |
|
|
IPIX Important Levels Intraday
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
IPIX Forecast April 2024
| 4th UP Forecast | 0.08 |
| 3rd UP Forecast | 0.06 |
| 2nd UP Forecast | 0.05 |
| 1st UP Forecast | 0.04 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | -0.01 |
| 3rd DOWN Forecast | -0.02 |
| 4th DOWN Forecast | -0.04 |
IPIX Weekly Forecast
| 4th UP Forecast | 0.06 |
| 3rd UP Forecast | 0.05 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.03 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | 0.00 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.02 |
IPIX Forecast2024
| 4th UP Forecast | 0.14 |
| 3rd UP Forecast | 0.1 |
| 2nd UP Forecast | 0.08 |
| 1st UP Forecast | 0.05 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -0.06 |
| 4th DOWN Forecast | -0.1 |
Innovation Pharmaceuticals Inc ( OTCQB USA Symbol : IPIX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IPIX Business Profile
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. Address: 301 Edgewater Place, Wakefield, MA, United States, 01880
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service